Organogenesis Holdings (ORGO) Net Cash Flow Growth (5y) (2021 - 2026)
Organogenesis Holdings (ORGO) Net Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn |
| 10 | Organogenesis Holdings | 325.24 Mn | 233.14 Mn | 11.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.09% |
| Dec 31, 2025 | -8.97% |
| Sep 30, 2025 | -19.34% |
| Jun 30, 2025 | -42.24% |
| Mar 31, 2025 | -14.01% |
| Dec 31, 2024 | 2.07% |
| Sep 30, 2024 | 8.20% |
| Jun 30, 2024 | 16.08% |
| Mar 31, 2024 | -29.34% |
| Dec 31, 2023 | 26.43% |
| Sep 30, 2023 | -17.63% |
| Jun 30, 2023 | -25.00% |
| Mar 31, 2023 | -57.32% |
| Dec 31, 2022 | -18.03% |
| Sep 30, 2022 | -96.34% |
| Jun 30, 2022 | 89.19% |
| Mar 31, 2022 | -61.18% |
| Dec 31, 2021 | 44.72% |
| Sep 30, 2021 | 167.74% |
| Mar 31, 2021 | -220.53% |